Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Iskander KS"'
Autor:
Landgren O; Memorial Sloan Kettering Cancer Center, New York, NY, USA. landgrec@mskcc.org., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Jakubowiak A; University of Chicago Medicine, Chicago, IL, USA., Mohty M; Saint-Antoine Hospital, Sorbonne University, INSERM UMRs 938, Paris, France., Iskander KS; Amgen Inc., Thousand Oaks, CA, USA., Mezzi K; Amgen Inc., Thousand Oaks, CA, USA., Siegel DS; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Publikováno v:
Leukemia [Leukemia] 2019 Sep; Vol. 33 (9), pp. 2127-2143. Date of Electronic Publication: 2019 Jul 24.
Autor:
Dimopoulos M; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Siegel D; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., White DJ; Division of Hematology, Dalhousie University, Halifax, NS, Canada.; Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada., Boccia R; Center for Cancer and Blood Disorders, Bethesda, MD., Iskander KS; Amgen, Inc., Thousand Oaks, CA., Yang Z; Amgen, Inc., Thousand Oaks, CA., Kimball AS; Amgen, Inc., Thousand Oaks, CA., Mezzi K; Amgen, Inc., Thousand Oaks, CA., Ludwig H; Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria; and., Niesvizky R; Center for Myeloma, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.
Publikováno v:
Blood [Blood] 2019 Jan 10; Vol. 133 (2), pp. 147-155. Date of Electronic Publication: 2018 Nov 26.
Autor:
Leleu X; Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France. Electronic address: xavier.leleu@chu-poitiers.fr., Martin TG; Adult Leukemia and Bone Marrow Transplantation Program, University of California, San Francisco, CA., Einsele H; Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany., Lyons RM; Department of Hematology, Texas Oncology and US Oncology Research, San Antonio, TX., Durie BGM; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA., Iskander KS; Global Medical Affairs, Amgen Inc, Thousand Oaks, CA., Ailawadhi S; Department of Hematology, Mayo Clinic, Jacksonville, FL.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2019 Jan; Vol. 19 (1), pp. 9-22. Date of Electronic Publication: 2018 Sep 05.
Autor:
Chari A; Hematology/Oncology, Mount Sinai School of Medicine, New York, NY., Stewart AK; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ., Russell SD; Department of Medicine, Duke University Medical Center, Durham, NC., Moreau P; Department of Hematology, University Hospital Hotel-Dieu, Nantes, France., Herrmann J; Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Phoenix, AZ., Banchs J; Department of Cardiology, Division of Internal Medicine, MD Anderson Cancer Center, Houston, TX., Hajek R; Department of Haematooncology, Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic., Groarke J; Department of Cardiology, Division of Internal Medicine, Partners/Brigham and Women's Hospital, Boston, MA., Lyon AR; Department of Cardiology, Imperial College London, London, United Kingdom.; Cardiology, Royal Brompton Hospital, London, United Kingdom., Batty GN; Amgen Inc., Thousand Oaks, CA; and., Ro S; Amgen Inc., Thousand Oaks, CA; and., Huang M; Amgen Inc., Thousand Oaks, CA; and., Iskander KS; Amgen Inc., Thousand Oaks, CA; and., Lenihan D; Cardiovascular Division, Washington University in St. Louis, St. Louis, MO.
Publikováno v:
Blood advances [Blood Adv] 2018 Jul 10; Vol. 2 (13), pp. 1633-1644.
Autor:
Goldschmidt H; a Division of Multiple Myeloma , Universitatsklinikum Heidelberg , Heidelberg , Germany., Moreau P; b Department of Hematology , University of Nantes , Nantes , France., Ludwig H; c Wilhelminen Cancer Research Institute , Wilhelminenspital , Vienna , Austria., Niesvizky R; d Multiple Myeloma Center, Weill Cornell Medical College , New York Presbyterian Hospital , New York , NY , USA., Chng WJ; e Department of Haematology-Oncology , National University Cancer Institute, National University Health System, Singapore and Cancer Science Institute of Singapore, National University of Singapore , Singapore., Joshua D; f Institute of Haematology , Royal Prince Alfred Hospital, the University of Sydney , Camperdown , New South Wales , Australia., Weisel K; g Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology , Universitatsklinikum Tubingen , Tubingen , Germany., Spencer A; h Division of Blood Cancers , Alfred Health-Monash University , Melbourne , Victoria , Australia., Orlowski RZ; i Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, The University of Texas , Houston , TX , USA., Feng S; j Amgen, Inc , Thousand Oaks , CA , USA., Iskander KS; j Amgen, Inc , Thousand Oaks , CA , USA., Dimopoulos MA; k Department of Clinical Therapeutics, School of Medicine , National and Kapodistrian University of Athens , Athens , Greece.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2018 Jun; Vol. 59 (6), pp. 1364-1374. Date of Electronic Publication: 2017 Sep 22.